Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors

Journal of Medicinal Chemistry

Volumn 39, Issue 26, 1996, Pages 5064-5071

  Cho, Sung Jin ^a   Serrano Garsia, Maria Luisa ^a,b   Bier, Jim ^a,c   Tropsha, Alexander ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c FERRUM COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; EDROPHONIUM; PHYSOSTIGMINE; TACRINE;

ARTICLE; DRUG CONFORMATION; DRUG STRUCTURE; MOLECULAR MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

ACETYLCHOLINESTERASE; BINDING SITES; CHOLINESTERASE INHIBITORS; MOLECULAR STRUCTURE;

EID: 0000261607     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950771r     Document Type: Article

References (33)

1. Martin, Y. C.; Danaher, E. B.; May, C. S.; Weininger, D.; Van Drie, J. H. Strategies in Drug Design Based on 3D-Structures of Ligands. In QSAR: Quantitative Structure-Activity Relationships in Drug Design; Fauchere, J. L., Ed.; Alan R. Liss: New York, 1989; pp 177-181.
2. Marshall, G. R.; Barry, C. D.; Bosshard, H. E.; Dammkoehler, R. A.; Dunn, D. A. The Conformational Parameter in Drug Design; The Active Analog Approach. In Computer-Assisted Drug Design; Olsen, E. C., Christoffersen, R. E., Eds.; ACS Symposium Series No. 112; American Chemical Society: Washington, DC, 1979; pp 205-226.
3. Martin, Y. C. Overview of Concepts and Methods in Computer-Assisted Rational Drug Design. Methods Enzymol. 1991, 203, 587-613.
4. Cramer, R. D. III; Patterson, D. E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape on Binding of Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
5. Boyd, D. B. Successes of Computer-Assisted Molecular dessign. In Reviews in Computational Chemistry I; Lipkowitz, K. B., Boyd, D. B., Eds.; VCH Publishers: New York, 1990; pp 355-372.
6. Bugg, C. E.; Carson, W. M.; Montgomery, J. A. Drugs by Design. Sci. Am. 1993, 269, 92-98.
7. Martin, Y. C.; Bures, M. G.; Danaher, E. A.; DeLazzer, J.; Lico, I.; Pavlik, P. A. A Fast New Approach to Pharmacophore Mapping and Its Application to Dopaminergic and Benzodiazepine Agonists. J. Comput.-Aided Mol. Des. 1993, 7, 83-102.
8. Goodford, P. J. A Computational Procedure for Determining Energetically Favorable Binding Sites on Biologically Important Macromolecules. J. Mad. Chem. 1980, 28, 849-957.
9. Meng, E. C.; Shoichet, B. K.; Kuntz, I. D. Automated Docking with Grid-Based Energy Evaluation. J. Comput. Chem. 1992, 13, 505-524.
10. Ferguson, D. M.; Radmer, R. J.; Kollman, P. A. Determination of the Relative Binding Free Energies of Peptide Inhibitors to the HIV-1 Protease. J. Med. Chem. 1991, 34, 2654-2659.
11. Tropsha, A.; Hermans, J. Application of Free Energy Simulations to the Binding of a Transition-State-Analog Inhibitors to HIV Protease. Protein Eng 1992, 5, 29-33.
12. Waller, C. L.; Oprea, T. I.; Giolitti, A.; Marshall, G. R. Three-Dimensional QSAR of Human Immunodeficiency Virus (I) Protease Inhibitors. 1. A CoMFA Study Employing Experimentally-Determined Alignment Rules. J. Med. Chem. 1993, 36, 4152-4160.
13. Taylor, P. Anticholinesterase Agents. In The Pharmacological Basis of Therapeutics; Gilman, A. G., Rail, T. W., Nies, A. S., Taylor, P., Eds.; Pergamon: New York, 1990; pp 131-149.
14. Hakansson, L. Mechanism of Action of Cholinesterase Inhibitors in Alzheimer's Disease. Acta Neurol. Scand. Suppl. 1993, 149, 7-9.
15. Sirvio, J.; Riekkinen, P. J. Brain and Cerebrospinal Fluid Cholinesterases in Alzheimer's Disease, Parkinson's Disease and Aging. A Critical Review of Clinical and Experimental Studies. J. Neural Transm.: Parkinson's. Dis. Dementia Sect. 1992, 4, 337-358.
16. Linton, D. M.; Philcox, D. Myasthenia Gravis. DM, Dis. Mon. 1990, 36, 593-637.
17. Villalobos, A.; Blake, J. F.; Biggers, C. K.; Butler, T. W.; Chapin, D. S.; Chen, Y. L.; Ives, J. L.; Jones, S. B.; Liston, D. R.; Nagel, A. A. Novel Benzoisoxazole Derivatives as Potent and Selective Inhibitors of Acetylcholinesterase. J. Med. Chem. 1994, 37, 2721-2734.
18. Ishihara, Y.; Hirai, K.; Miyamoto, M.; Goto, G. Central Cholinergic Agents. 6. Synthesis and Evaluation of 3-[1-(Phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)- 1-propanones and Their Analogs as Central Selective Acetylcholinesterase Inhibitors. J. Med. Chem. 1994, 37, 2292-2299.
19. Chen, Y. L.; Liston, D.; Nielsen, J.; Chapin, D.; Dunaiskis, A.; Hedberg, K.; Ives, J.; Johnson, J., Jr.; Jones, S. Syntheses and Anticholinesterase Activity of Tetrahydrobenzazepine Carbamates. J. Med. Chem. 1994, 37, 1996-2000.
20. Vidaluc, J. L.; Calmel, F.; Bigg, D.; Carilla, E.; Stenger, A.; Chopin, P.; Briley, M. Novel [2-(4-Piperidinyl]ethyl](thio)ureas: Synthesis and Antiacetylcholinesterase Activity. J. Med. Chem. 1994, 37, 689-695.
21. Sasho, S.; Obase, H.; Ichikawa, S.; Kitazawa, T.; Nonaka, H.; Yoshizaki, R.; Ishii, A.; Shuto, K. Synthesis of 2-Imidazolidinylidenepropanedinitrile Derivatives as Stimulators of Gastrointestinal Motility. J. Med. Chem. 1993, 36, 572-579.
22. Sussman, J. L.; Harel, M.; Frolow, F.; Oefner, C.; Goldman, A.; Toker, L.; Silman, I. Atomic Structure of Acetylcholinesterase from Torpedo californica: A Prototypic Acetylcholine-Binding Protein. Science 1991, 253, 8872-8879.
23. Harel, M.; Schalk, I.; Ehret-Sabatier, L.; Bouet, F.; Goeldner, M.; Hirth, C.; Axelsen, P. H.; Silman, I.; Sussman, J. L. Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc. Natl. Acad. Sci. U.S.A.. 1993, 90, 9031-9035.
24. 2 Guided Region Selection for Comparative Molecular Field Analysis (CoMFA): A Simple Method to Achieve Consistent Results. J. Med. Chem. 1995, 38, 1060-1066.
25. 2-GRS Approach. J. Med. Chem. 1996, 39, 1383-1395.
26. The program Sybyl 6.0 is available from Tripos Associates, 1699 South Hanley Road, St Louis, MO 63144.
27. Clark, M.; Cramer, R. D., III; Van Opdenbosh, N. Validation of the General Purpose Tripos 5.2 Force Field. J. Comput. Chem. 1989, 10, 982-1012.
28. Lee, B. H.; Stelly, T. C.; Colucci, W. J.; Garcia, G.; Gandour, R. D.; Quinn, D. M. Inhibition of Acetylcholinesterase by Hemicholiniums, Conformationally Constrained Choline Analogues. Evaluation of Aryl and Alkyl Substituents. Comparisons with Choline and (3-Hydroxyphenyl)trimethylammonium. Chem. Res. Toxicol. 1992, 5, 411-418.
29. Thanei-Wyss, P.; Waser, P. G. Interaction of Quaternary Ammonium Compounds with Acetylcholinesterase: Characterization of the Active Site. Eur. J. Pharmacol. 1989, 172, 165-173.
30. Cocolas, G. H.; Cranford, J. G.; Choi, H. S. Y. Studies on the Conformational Requirements of Substrate and Inhibitor on Acetylcholinesterase. J. Med. Chem. 1974, 17, 938-943.
31. Atack, J. R.; Yu, Q. S.; Soncrant, T. T.; Brossi, A.; Rapoport, S. I. Comparative Inhibitory Effects of Various Physostigmine Analogs Against Acetyl- and Butyrylcholinesterases. J. Pharmacol. Exp. Ther. 1989, 249, 194-202.
32. 50). Bioquem. Pharmacol. 1973, 22, 3099-3108.
33. Jones, J. P.; He, M.; Trager, W. F.; Rettie, A. E. Three-Dimensional Quantitative Structure-Activity Relationship for Inhibitors of Cytochrome P4502C9. Drug Metab. Dispos. 1996, 24, 1-6.